Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXRX Recursion Pharmaceuticals, Inc.

休市中 11-22 16:00:00 EST

5.70

-0.05

-0.87%

盘后5.80

+0.10+1.75%

19:59 EST

最高5.99	最低5.60	成交量1,370万
今开5.78	昨收5.75	日振幅6.78%
总市值16.35亿	流通市值14.65亿	总股本2.87亿
成交额7,921万	换手率5.33%	流通股本2.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXRX","market":"US","secType":"STK","nameCN":"Recursion Pharmaceuticals, Inc.","latestPrice":5.7,"timestamp":1732309200000,"preClose":5.75,"halted":0,"volume":13702448,"hourTrading":{"tag":"盘后","latestPrice":5.8,"preClose":5.7,"latestTime":"19:59 EST","volume":448898,"amount":2564101.7064,"timestamp":1732323592450},"delay":0,"floatShares":256999999,"shares":286838236,"eps":-1.537942,"marketStatus":"休市中","marketStatusCode":7,"change":-0.05,"latestTime":"11-22 16:00:00 EST","open":5.78,"high":5.99,"low":5.6,"amount":79205465.989824,"amplitude":0.067826,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.537942,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"listingDate":1618545600000,"adjPreClose":5.75,"preHourTrading":{"tag":"盘前","latestPrice":5.8101,"preClose":5.75,"latestTime":"09:29 EST","volume":87968,"amount":510271.40326399996,"timestamp":1732285790447},"postHourTrading":{"tag":"盘后","latestPrice":5.8,"preClose":5.7,"latestTime":"19:59 EST","volume":448898,"amount":2564101.7064,"timestamp":1732323592450},"volumeRatio":1.14854,"impliedVol":0.7854,"impliedVolPercentile":0.3254},"requestUrl":"/m/hq/s/RXRX","defaultTab":"news","newsList":[{"id":"2484145840","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大跌5.10%报5.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484145840","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484145840?lang=zh_cn&edition=full","pubTime":"2024-11-20 23:20","pubTimestamp":1732116032,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日23时20分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.10%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Forte Biosciences, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为1056.92%、574.74%、215.39%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为183.66%、103.77%、73.14%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120232032a248da48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120232032a248da48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4548","RXRX"],"gpt_icon":0},{"id":"2482738738","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:30","pubTimestamp":1731335459,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时30分，Recursion Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.07%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Cero Therapeutics Holdings, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Revelation Biosciences, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为405.97%、124.75%、60.87%，振幅较大的相关个股有Larimar Therapeutics, Inc.、Igm Biosciences, Inc.、Crispr Therapeutics Ag，振幅分别为103.14%、103.07%、103.04%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223059a22ce332&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223059a22ce332&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4139","BK4548"],"gpt_icon":0},{"id":"2479034795","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479034795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479034795?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:08","pubTimestamp":1730387303,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时08分，Recursion Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.01%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.51%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Aditxt, Inc.、Evogene Ltd.、Palisade Bio, Inc.较为活跃，换手率分别为245.70%、231.86%、163.10%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Vaccinex, Inc.、Cingulate Inc C/Wts 10/12/2026 ，振幅分别为46.15%、41.09%、39.30%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031230824971a397c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031230824971a397c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4548","RXRX"],"gpt_icon":0},{"id":"2478489564","title":"Recursion Pharmaceuticals, Inc.盘中异动 大幅拉升5.09%报6.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478489564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478489564?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:46","pubTimestamp":1730123203,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时46分，Recursion Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.09%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为570.50%、50.52%、38.74%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monopar Therapeutics Inc.、Monte Rosa Therapeutics, Inc.，振幅分别为45.41%、28.94%、23.31%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214643971a2a5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214643971a2a5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RXRX","BK4548"],"gpt_icon":0},{"id":"2476812704","title":"Recursion Pharmaceuticals, Inc.盘中异动 下午盘大幅跳水5.06%报6.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476812704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476812704?lang=zh_cn&edition=full","pubTime":"2024-10-18 02:20","pubTimestamp":1729189225,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日02时20分，Recursion Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.06%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Molecular Templates, Inc.、Notable Labs, Ltd.、180 Life Sciences Corp.较为活跃，换手率分别为2595.81%、932.93%、279.96%，振幅较大的相关个股有Molecular Templates, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为259.74%、147.48%、104.84%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018022025ab6ae123&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018022025ab6ae123&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4548","RXRX"],"gpt_icon":0},{"id":"2474884772","title":"Recursion Pharmaceuticals, Inc.盘中异动 临近收盘快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474884772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474884772?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:43","pubTimestamp":1728416633,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时43分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.02%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Bio-Path Holdings, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2644.10%、2513.91%、300.15%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Vaccinex, Inc.、Bio-Path Holdings, Inc.，振幅分别为66.06%、57.92%、57.39%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009034353ab68869f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009034353ab68869f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4139","BK4548"],"gpt_icon":0},{"id":"2472337955","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472337955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472337955?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:22","pubTimestamp":1727720561,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时22分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.01%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Capricor Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Aditxt, Inc.、Seelos Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为216.01%、60.77%、58.52%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为87.30%、85.25%、48.53%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001022241ab673105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001022241ab673105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4539","RXRX","BK4139"],"gpt_icon":0},{"id":"1140472704","title":"英伟达支持的Recursion初步药物数据不佳，AI生物科技股下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1140472704","media":"华尔街洞察","labels":["analysis"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140472704?lang=zh_cn&edition=full","pubTime":"2024-09-04 07:55","pubTimestamp":1725407758,"startTime":"0","endTime":"0","summary":"周二，受到$英伟达$支持的Recursion Pharmaceuticals在公布其主要药物REC-994的二期临床试验初步结果后，AI驱动的生物科技公司股价普遍下跌。2023年7月，Recursion因获得$英伟达$5000万美元的投资而引发了AI驱动的生物制药股票的上涨。然而，在公布试验结果后，Recursion股价暴跌约11%，创下两个月以来的最大盘中跌幅，尽管成交量低于平均水平。另一个AI生物科技公司Exscientia ，Recursion上个月刚同意收购该公司，其股价也下跌约9%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"analysis","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ199S13.USD","IE00BJLML261.HKD","IE00BN29S564.USD","IE00BJJMRY28.SGD","BK4549","IE0034235188.USD","BK4581","IE00B4JS1V06.HKD","IE0004445239.USD","BK4548","IE00BMPRXR70.SGD","LU0061474960.USD","LU0053666078.USD","IE00B19Z8X17.USD","159837","LU0077335932.USD","BK4527","NVDA","BK4585","BK4543","IE00BFSS8Q28.SGD","IE00BMPRXN33.USD","IE0004086264.USD","BK4567","BK4592","LU0061474705.USD","IE00BK4W5L77.USD","RXRX","IE00BMPRXQ63.HKD","IE0009356076.USD","IE00B1BXHZ80.USD","IE00BDCRKT87.USD","BK4532","LU0057025933.USD","IE0034235295.USD","BK4551","IE00BDRTCR15.USD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","BK4534","BK4529","IE00B19Z9505.USD","IE00BD6J9T35.USD","IE00B7KXQ091.USD","BK4554"],"gpt_icon":0},{"id":"2464838123","title":"BUZZ--美国股票走势-沃尔格林、铜矿商、西蒙地产","url":"https://stock-news.laohu8.com/highlight/detail?id=2464838123","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464838123?lang=zh_cn&edition=full","pubTime":"2024-09-04 00:04","pubTimestamp":1725379486,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      9月3日 - 华尔街主要股指下跌超过1%，因为投资者在评估最新的工厂活动数据，本周还将公布一系列劳动力市场报告，这些报告可能会影响美联储今年放松货币政策的程度。美东时间11:48，道琼斯工业平均指数  下跌1.08%，报41,114.45 点。标普500指数  下跌1.43%，报5567.76点；纳斯达克综合指数  下跌2.39%，报17290.837点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XOM","IMAX","DJX","PSQ","PSX","KO",".DJI","FDS","AQB","DKS","XYL","PCVX","NWSA","COP","OKE","SOC","HGmain","IFF","MTB","RIVN","RXRX","MNQmain","SPG","BUZZ","MU","TCOM","DYN","SCCO","GOOGL","SGRP","DVN",".IXIC","TQQQ","NVCR","WBA","AAOI","LUV","FANG","SQ","CME","MUR","JAZZ","CVX","NOC","SNGX","FCX","L","X","GOOG","MGM","BA","MRO"],"gpt_icon":1},{"id":"2464810807","title":"BUZZ-罕见疾病药物的中期研究数据喜忧参半，Recursion公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2464810807","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464810807?lang=zh_cn&edition=full","pubTime":"2024-09-03 22:09","pubTimestamp":1725372583,"startTime":"0","endTime":"0","summary":"    9月3日 - ** Nvidia支持的Recursion Pharmaceuticals公司  早盘股价下跌9.7%，至6.58美元。** 药物开发商称，在一项中期研究中，其治疗一种罕见脑相关疾病的实验性药物是安全和可耐受的  ** 这种名为 REC-994 的药物正在接受测试，以治疗脑海绵畸形，即小血管异常聚集形成病变，导致脑出血、癫痫发作和瘫痪。** 虽然最高剂量的 REC-994 在研究中显示出病变数量减少的迹象，但在 12 个月的治疗期结束时，患者或医生报告的病情改善情况尚未出现 - RXRX** 今年以来，股价下跌了 36.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RXRX","BUZZ","BK4139","BK4548"],"gpt_icon":0},{"id":"2464870047","title":"Recursion 公司的血管疾病药物在中期研究中达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2464870047","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464870047?lang=zh_cn&edition=full","pubTime":"2024-09-03 20:08","pubTimestamp":1725365335,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透9月3日 - Recursion Pharmaceuticals   周二表示，其治疗血管畸形的实验性药物在一项中期研究中达到了安全性和耐受性的主要目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":0},{"id":"2460687370","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460687370","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460687370?lang=zh_cn&edition=full","pubTime":"2024-08-20 02:26","pubTimestamp":1724091973,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日02时26分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.04%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.29%。其相关个股中，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为8809.81%、3737.99%、1261.19%，振幅较大的相关个股有Alzamend Neuro, Inc.、Virax Biolabs Group Limited、Revelation Biosciences Inc C/Wts 10/01/2027 ，振幅分别为405.90%、220.18%、198.02%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820022613971992ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820022613971992ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","RXRX","BK4539"],"gpt_icon":0},{"id":"2460363307","title":"Recursion Pharmaceuticals, Inc.2024财年第二财季实现净利润-97.54百万美元，同比减少27.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460363307","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460363307?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910646,"startTime":"0","endTime":"0","summary":"8月18日，Recursion Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-97.54百万美元，同比减少27.12%；其中营业收入为14.42百万美元，同比增加30.85%，每股基本收益为-0.40美元。从资产负债表来看，Recursion Pharmaceuticals, Inc.总负债1.91亿美元，其中短期债务16.72百万美元，资产负债比为4.07，流动比率为0.07。机构评级：截至2024年8月18日，当前有6家机构对Recursion Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.50美元，其中最低目标价为8.00美元，最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006289f340752&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408180006289f340752&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXRX"],"gpt_icon":0},{"id":"2459420874","title":"Recursion Pharmaceuticals, Inc.盘中异动 急速上涨5.10%报6.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459420874","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459420874?lang=zh_cn&edition=full","pubTime":"2024-08-15 21:31","pubTimestamp":1723728681,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日21时31分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.10%。截至发稿，该股报6.60美元/股，成交量13.1389万股，换手率0.05%，振幅0.96%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Cingulate Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Nutriband Inc C/Wts 涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为2325.69%、1456.73%、335.42%，振幅较大的相关个股有Cingulate Inc.、Celcuity Inc.、Absci Corporation，振幅分别为28.18%、9.31%、9.11%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213121a1d47062&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815213121a1d47062&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4548","BK4139"],"gpt_icon":0},{"id":"1130739220","title":"异动解读 | Recursion Pharmaceuticals, Inc.盘后大涨8.96% 财报数据和机构评级利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1130739220","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130739220?lang=zh_cn&edition=full","pubTime":"2024-08-14 08:01","pubTimestamp":1723593671,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.(RXRX)股价今日盘后大涨8.96%,引发市场关注。根据相关新闻报道,该公司最新的财报数据和机构评级或许是导致股价上涨的主要原因。\n\n财报数据显示,Recursion Pharmaceuticals去年实现营业收入1442万美元,虽然净利润为负值,但毛利为132万美元,市盈率为-3.82倍,反映出公司一定的盈利能力和成长潜力。\n\n此外,机构评级方面,有7家机构参与评级,其中29%的机构给予买入评级,71%的机构给予持有评级,没有卖出评级。这表明机构对该公司的前景持乐观态度,有利于提振投资者信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":0},{"id":"1181083467","title":"异动解读 | Recursion Pharmaceuticals股价大涨5.31% 机构看好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1181083467","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181083467?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:58","pubTimestamp":1723561115,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc.(RXRX)股价今日盘中大涨5.31%,引发市场关注。据报道,该公司最新的财报数据和机构评级或许是导致股价上涨的主要原因。\n\n财报数据显示,Recursion Pharmaceuticals去年实现营业收入1442万美元,虽然净利润为负值,但毛利为132万美元,市盈率为-3.82倍,反映出公司一定的盈利能力和成长潜力。\n\n此外,机构评级方面,有7家机构参与评级,其中29%的机构给予买入评级,71%的机构给予持有评级,没有卖出评级。这表明机构对该公司的前景持乐观态度,有利于提振投资者信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":0},{"id":"2459900080","title":"Recursion Pharmaceuticals, Inc.盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459900080","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459900080?lang=zh_cn&edition=full","pubTime":"2024-08-13 22:47","pubTimestamp":1723560444,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日22时47分，Recursion Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.14%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.71%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为131.36%、115.71%、26.94%，振幅较大的相关个股有冠科美博、Psyence Biomedical Ltd C/Wts 25/01/2029、Tempest Therapeutics, Inc.，振幅分别为52.50%、40.95%、39.71%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224724ab5d9c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813224724ab5d9c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RXRX","BK4548","BK4539"],"gpt_icon":0},{"id":"2458989415","title":"Recursion Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458989415","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458989415?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:57","pubTimestamp":1723471074,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时57分，Recursion Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.10%。Recursion Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。其相关个股中，Revance Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Oragenics Inc.、Revance Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为55.48%、32.58%、11.59%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Cingulate Inc.，振幅分别为40.71%、26.33%、23.72%。Recursion Pharmaceuticals, Inc.公司简介：Recursion Pharmaceuticals Inc是一家处于临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812215754af971697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812215754af971697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXRX","BK4139","BK4548"],"gpt_icon":0},{"id":"1188627259","title":"异动解读 | Recursion Pharmaceuticals宣布68.8亿美元收购Exscientia 股价大涨7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188627259","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188627259?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:09","pubTimestamp":1723190946,"startTime":"0","endTime":"0","summary":"人工智能驱动的药物研发公司Recursion Pharmaceuticals今日盘中股价大涨7.06%,引发市场广泛关注。消息面上,RXRX宣布将以全股票交易的方式,以6.88亿美元的价格收购同行Exscientia。根据协议,Exscientia股东每持有一股普通股,将获得0.7729股Recursion A类普通股。交易完成后,Recursion股东将拥有合并后公司约74%的股份,而Exscientia股东将拥有其余股份。合并后的Recursion将由联合创始人兼首席执行官克里斯·吉布森领导,而Exscientia的临时首席执行官David Hallett将出任首席科学官。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":0},{"id":"1144454179","title":"异动解读 | Recursion Pharmaceuticals股价大涨 将以6.88亿美元收购Exscientia","url":"https://stock-news.laohu8.com/highlight/detail?id=1144454179","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144454179?lang=zh_cn&edition=full","pubTime":"2024-08-09 16:06","pubTimestamp":1723190782,"startTime":"0","endTime":"0","summary":"人工智能驱动的药物研发公司Recursion Pharmaceuticals今日股价大涨5.49%,引发市场广泛关注。消息显示,Recursion已同意以6.88亿美元的全股票交易收购规模较小的竞争对手Exscientia。根据协议,Exscientia股东每持有1股普通股,将获得0.7729股Recursion A类普通股。部分股份将以现金支付。交易完成后,Recursion股东将拥有合并后公司约74%的股份,而Exscientia股东将持有其余股份。合并后的Recursion将由克里斯·吉布森继续担任首席执行官,Exscientia临时CEO大卫·哈利特将出任首席科学官。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.recursion.com","stockEarnings":[{"period":"1week","weight":-0.0769},{"period":"1month","weight":-0.0995},{"period":"3month","weight":-0.2702},{"period":"6month","weight":-0.3777},{"period":"1year","weight":-0.1593},{"period":"ytd","weight":-0.4219}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Recursion Pharmaceuticals, Inc.最初成立于2013年11月4日，并在特拉华州注册成立 。 Recursion是一家生物技术公司，结合了自动化，人工智能，机器学习，体内验证功能和高度跨职能的团队，以发现能够扩大人们对生物学的集体理解的新型药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.091346},{"month":2,"riseRate":0.333333,"avgChangeRate":0.111205},{"month":3,"riseRate":0,"avgChangeRate":-0.262334},{"month":4,"riseRate":0,"avgChangeRate":-0.211528},{"month":5,"riseRate":0.5,"avgChangeRate":0.168429},{"month":6,"riseRate":0.5,"avgChangeRate":0.118076},{"month":7,"riseRate":0.75,"avgChangeRate":0.213595},{"month":8,"riseRate":0.25,"avgChangeRate":-0.10569},{"month":9,"riseRate":0.25,"avgChangeRate":-0.072683},{"month":10,"riseRate":0,"avgChangeRate":-0.131747},{"month":11,"riseRate":0.25,"avgChangeRate":0.022169},{"month":12,"riseRate":0.333333,"avgChangeRate":0.05185}],"exchange":"NASDAQ","name":"Recursion Pharmaceuticals, Inc.","nameEN":"Recursion Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Recursion Pharmaceuticals, Inc.,RXRX,Recursion Pharmaceuticals, Inc.股票,Recursion Pharmaceuticals, Inc.股票老虎,Recursion Pharmaceuticals, Inc.股票老虎国际,Recursion Pharmaceuticals, Inc.行情,Recursion Pharmaceuticals, Inc.股票行情,Recursion Pharmaceuticals, Inc.股价,Recursion Pharmaceuticals, Inc.股市,Recursion Pharmaceuticals, Inc.股票价格,Recursion Pharmaceuticals, Inc.股票交易,Recursion Pharmaceuticals, Inc.股票购买,Recursion Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Recursion Pharmaceuticals, Inc.(RXRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Recursion Pharmaceuticals, Inc.(RXRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}